Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 1
1 (33.3%)5-Way Crossover Study to Compare the Safety, Tolerability and Pharmacokinetics of New Oral Cannabinoid Formulations Administered as Single Doses, With Buccal Sativex®, in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2017-06-28
- Last Posted Date
- 2017-09-20
- Lead Sponsor
- PhytoTech Therapeutics, Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT03201835
- Locations
- 🇮🇱
Clinical Research Center (CRC)- Souraskey Medical center, Tel Aviv, Israel
Evaluation of the Safety, Tolerability, and Efficacy of Orally Administered PTL201 in MS Patients With Spasticity-related Symptoms
- First Posted Date
- 2016-12-29
- Last Posted Date
- 2017-09-28
- Lead Sponsor
- PhytoTech Therapeutics, Ltd.
- Target Recruit Count
- 70
- Registration Number
- NCT03005119
- Locations
- 🇮🇱
Sheba medical center, Tel Hashomer, Ramat gan, Israel
A Study to Evaluate the Safety, Tolerability and Efficacy of Oral Administration of PTL101 (Cannabidiol) as an Adjunctive Treatment for Pediatric Intractable Epilepsy
Phase 2
Completed
- Conditions
- Epilepsy Intractable
- Interventions
- Drug: PLT101
- First Posted Date
- 2016-12-08
- Last Posted Date
- 2018-09-06
- Lead Sponsor
- PhytoTech Therapeutics, Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT02987114
- Locations
- 🇮🇱
Pediatric Epilepsy department- Souraskey Medical center, Tel Aviv, Israel
News
No news found